# Proxsys Rx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proxsys-rx

- Industry: Healthcare
- Headquarters: Birmingham, US
- Website: www.proxsysrx.com
- Latest round: Series A (Dec 14, 2020)
- Investors on record: 1

## About

Proxsys Rx, LLC provides innovative pharmacy solutions that enhance patient care and optimize hospital pharmacy operations, focusing on prescription delivery, pharmacy outsourcing, and 340B program support.Founded in 2013 and headquartered in Birmingham, US, Proxsys Rx, LLC specializes in pharmacy solutions designed to assist hospital systems. The company has executed one deal, with its most recent deal occurring on December 14, 2020. George Salem serves as the CEO, leading the company in its service offerings and strategic direction.ProxsysRx offers a comprehensive suite of pharmacy solutions aimed at enhancing patient care and optimizing hospital pharmacy operations. Their core product offerings include bedside prescription delivery, retail pharmacy outsourcing, 340B program optimization, and employee health benefits savings. These services are designed to address critical challenges faced by hospital systems, such as reducing readmission rates, managing pharmacy benefits, and streamlining prescription payment assistance. ProxsysRx serves 32 hospital systems, providing significant savings and minimizing capital risks for healthcare providers. The solutions are tailored for a variety of geographical markets, specifically targeting healthcare facilities primarily in the United States, where they directly assist hospitals and their patients in navigating the complexities of pharmacy management and patient engagement.The revenue structure of ProxsysRx is built on a model that leverages partnerships with healthcare facilities, focusing on B2B transactions. The company collaborates with hospital systems to implement its pharmacy solutions, charging clients based on the services rendered without imposing upfront costs. This approach includes revenue-sharing agreements and performance-based incentives, allowing hospitals to benefit from improved patient care while minimizing financial risk. ProxsysRx’s offerings, including 340B optimization and prescription payment assistance, operate under a cost-effective framework designed to maximize returns for their clients. By creating a seamless integration of pharmacy services within hospital settings, ProxsysRx enhances both operational efficiency and financial outcomes for its partners.In December 2020, Proxsys Rx, LLC raised an undisclosed amount of Series A funding led by new investor Fulcrum Equity Partners, which will support its future initiatives. The company plans to develop new products targeting enhanced pharmacy management solutions, although specific release dates have yet to be announced. ProxsysRx aims to expand its services into additional healthcare markets across the United States, focusing on regions with significant demand for pharmacy optimization. This growth strategy will utilize the recent funding to bolster product development and market outreach.

## Funding rounds

- Series A, Dec 14, 2020 — Fulcrum Equity Partners

## Investors

- Fulcrum Equity Partners (https://capitalatlas.ai/funds/fulcrum-equity-partners) — Series A